Financial Year |
September 30 2018 |
Monetary Funds |
859,741,912.14 |
Held-for-trading Financial Assets |
836,025,172.31 |
Notes Receivable |
5,982,000.00 |
Accounts Receivable |
254,577,130.98 |
Advances to Suppliers |
7,728,193,876.90 |
Other Receivables |
733,832,744.14 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
25,282,459,558.85 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
904,541,589.93 |
Total Current Assets |
36,605,353,985.25 |
Available-for-Sale Financial Asset |
199,995,000.00 |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
3,780,682,830.72 |
Investment Properties |
60,624,663.45 |
Fixed Assetes |
623,966,276.83 |
Under-construction Projects |
29,730,209.45 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
259,413,956.97 |
R&D expenses |
-- |
Goodwill |
2,694,905,046.30 |
Long-Term Deferred and Prepaid Expenses |
132,239,057.57 |
Deferred Income Tax Assets |
316,337,270.54 |
Other Non-Current Assets |
237,591,679.38 |
Sub-Total of Non-Current Assets |
8,335,485,991.21 |
Total Assets |
44,940,839,976.46 |
Short-Term Loans |
3,073,436,357.15 |
Trading Financial liabilities |
18,186,245.23 |
Notes Payable |
-- |
Accounts Payable |
-- |
Accounts Received In Advance |
2,594,827,168.59 |
Employee Compensation Payable |
75,209,836.88 |
Taxes Payable |
189,035,919.32 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
5,526,414,762.46 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
12,541,906,075.21 |
Other Current Liabilities |
23,958,452.85 |
Sub-Total of Current Liabilities |
26,299,736,043.46 |
Long-term Loans |
11,576,073,762.30 |
Bonds Payable |
250,000,000.00 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
25,056,629.04 |
Sub-Total of Non-Current Liabilities |
11,929,682,909.42 |
Total Liabilities |
38,229,418,952.88 |
Paid-In Capital(Or Share Stock) |
8,390,601,199.00 |
Capital Surplus |
784,920,229.11 |
Surplus Reserve |
153,701,638.18 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-3,524,928,787.85 |
Minority Stockholder's Interest |
1,048,894,396.36 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,662,526,627.22 |
Owner's Equity(Stockholder's Equity) |
6,711,421,023.58 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
44,940,839,976.46 |